Investorideas.com newswire, breaking news for marijuana, cannabis and hemp stocks

Thursday 10 June 2021

Tilray Shares Climb Higher on Roll Out of New Medical Cannabis Brand Symbios

Tilray Shares Climb Higher on Roll Out of New Medical Cannabis Brand Symbios

Investor Ideas #Potcasts 574, #Cannabis News and #Stocks on the Move; (CSE: $CRFT.C), (TSX: $VLNS.TO) (OTCQX: $VLNCF) (TSXV: $KHRN.V) (OTCQX: $KHRNF),(TSXV: $LOVE.V) (OTCQB: $LOVFF)

 



 

Investor Ideas #Potcasts 574, #Cannabis News and #Stocks on the Move; (CSE: $CRFT.C), (TSX: $VLNS.TO) (OTCQX: $VLNCF) (TSXV: $KHRN.V) (OTCQX: $KHRNF),(TSXV: $LOVE.V) (OTCQB: $LOVFF)

 

Delta, Kelowna, BC, June 10, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2021/061021-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/06101CRFT-VLNS-KHRN-LOVE.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

In today’s podcast we look at a few private and public company announcements.

 

BC Craft Supply Co. Ltd., (CSE: CRFT), a diversified wellness company advancing cannabinoid and psychedelic innovation and psychotherapy, announced the launch of Grizzlers™, its flagship legacy cannabis brand into the markets of Ontario and Alberta.

 

Grizzlers™ is a legacy brand of pre-rolled craft cannabis; offering access to premium grown, hang dried, hand trimmed, and hand packed cannabis at accessible prices. Since its inception in 2017, Grizzlers™ quickly grew to be the most widely available legacy pre-roll producer in the country; achieving national distribution and wide-scale brand recognition.

Fueled by significant market anticipation, Grizzlers™ is launching two SKUs: a 7 x 0.5g (multi-pack) format and a 0.5g (single-serve) format, both in an Indica dominant Black Cherry Punch.

 

Market reception to date has been overwhelming. Ontario has ordered and shipped over 6,000 multi-packs, with re-orders already in tow from the Ontario Cannabis Store (“OCS”). Alberta has ordered 7,200 multi-packs, with over 20,000 single-serve packs ordered and shipped.

 

Grizzlers™ signature pre-roll Indica formats will be available to order at the OCS and through private retailers in Alberta as of June 15, 2021.

 

CRFT CEO, Matthew Watters, commented, “Our commitment to craft, focus on the flower, accessible pricing, and of course our legacy market clout, set Grizzlers™ apart from the rest. We’re excited to offer customers something they’ve been waiting for – a legacy market product at a legacy market price.”

 

Offering a reimagined vision for craft markets through collaboration, expertise, and adaptation, the Company has partnered with award-winning cannabis marketing company AHLOT, and cannabis cultivator and processor SAFARI FLOWER to expand Grizzlers™ distribution nationally and restore much need access to its existing following of loyal customers.

 

Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF), a vertically integrated producer of premium-grade cannabis and derivative products with one of the largest indoor cannabis cultivation facilities in Canada and the largest in Quebec, today announced that it has entered into a definitive agreement to acquire a one million square foot licensed cultivation and manufacturing facility in Valleyfield, Quebec from Medican Organic Inc., a wholly-owned subsidiary of The Green Organic Dutchman Holdings Ltd. , through an all-cash offer of $27 million plus the funding of certain deposit requirements of approximately $5.7 million.

 

"With this acquisition, Cannara continues to increase its footprint and create more jobs in its home province of Quebec," said Zohar Krivorot, President & Chief Executive Officer of Cannara. "Today's announcement reinforces our position as one of Canada's top leading producer of premium-grade cannabis and cannabis derivative products."

 

Located in Valleyfield, Quebec, the newly built state-of-the-art facility spans over 1,033,506 sq. ft. providing Cannara the ability to reach an annual cultivation capacity of 125,000 kg of premium-grade cannabis.

 

"While already marked by a strong balance sheet, we believe that this transaction significantly bolsters our business fundamentals, including annual output, profitability and overall financial position," said Nicholas Sosiak, Chief Financial Officer of Cannara. "Underlying this acquisition is our confidence in the broader market for competitively priced premium-grade cannabis products and our intention to capture a significant share of it."

 

"This is a major transition point for the Company, as we continue to execute our plans, allowing us to significantly reduce our debt while right-sizing our operations in Quebec without disruption," commented Sean Bovingdon, TGOD's CEO and Interim CFO. "Furthermore, we are pleased to be in position to provide for potential future growth in cultivation in Quebec through the leaseback of an appropriate portion of the Quebec Facility. Our portfolio of products is receiving positive reviews across the country and we look forward to providing Quebec with locally grown products, as demand continues to increase. Our balance sheet is being strengthened through the sale of excess assets and the elimination of term debt, and we expect annualized net cashflow savings of approximately $4 million in interest and overhead costs. This sets the foundation for the Company to take advantage of other growth opportunities in Canada and the United States," added Bovingdon.

 

Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF), a vertically integrated cannabis leader with core operations in Latin America and Europe, today announced the launch of its first ZereniaTM clinic outside of Colombia, in Lima, Peru. Following the success of the Company's clinic strategy in Colombia, the new clinic has been established as a strategic partnership between Khiron and Clinica Montesur, a specialized medical provider in Lima with over 90 physicians and more than 11,000 patient transactions annually.

 

Alvaro Torres, CEO and Director comments, "I am pleased to announce the first expansion of our Zerenia brand beyond Colombia. Knowing that prescription rates at our Zerenia clinics are 14 times higher than those of our external clinic partners, we are excited to bring a proven marketing, sales, and distribution model to a market of over ten million people. To date, our Zerenia clinics have played a vital role in not only introducing patients to Khiron products, but also in developing an exceptional patient experience and growing base of returning patients. As we continue to develop our unique, service-oriented platform, we are proud to introduce  Zerenia to the Peruvian market, where initial reception to our products has been strong since sales began late last year."

 

With over 30 years of experience in Peru, Clinica Montesur is dedicated to high quality care across 19 areas of specialization, including oncology, dermatology, ophthalmology, and psychology. As part of the strategic partnership, Clinica Montesur will provide clinic infrastructure, including its medical facility, clinic permits, systems, and medical staff, among others. The partnership will leverage Khiron's unique ZereniaTM medical cannabis model, including the Company's medical cannabis education platform, real-world evidence, and standard operating procedures. Patients of the clinic will be able to fill prescriptions for High THC and Low THC (CBD) medical cannabis at ten Farmacia Universal S.A.C. locations throughout Lima, as previously announced by the Company. 

 

The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF), a leading manufacturer of cannabis products, today announced that it has joined the Cannabis Council of Canada ("C3") – the national membership organization representing cannabis producers and processors licensed under the Cannabis Act. C3's mission is to advocate for and support the development, growth and integrity of Canada's legal cannabis industry.

 

Alongside other leading federal licensees and C3 affiliate members, Valens looks forward to contributing to a variety of initiatives geared toward shaping the growth of the legal cannabis industry and its commitment to protecting public health and safety. This includes working with all levels of government on policy development and regulatory reform related to responsible consumer education and marketing; sustainable recycling and environmental stewardship; and effective provincial distribution programs. Valens expects to participate in C3's established caucuses and committees, including those working on vape product safety standards and the taxation of cannabis vaping products. As a participant in C3's Sustainability Caucus, and in partnership with leading Canadian e-recycling provider Quantum Lifecycle Partners, Valens also expects to play a role in expanding C3's national vape recycling program, helping consumers dispose of vape hardware through cannabis retail locations across Alberta, British Columbia, and Ontario.

 

"C3 shares the same passion for bringing the benefits of regulated and legal cannabis to Canadians as we do, and we have long admired their efforts to create and uphold the highest standards for the industry," said Tyler Robson, Chief Executive Officer, Co-Founder and Chair of The Valens Company. "We look forward to working alongside our peers and sector leaders to influence and contribute to some of the most pressing matters facing Canada's legal cannabis industry."

 

C3 brings together licensed cultivators and licensed processors from across Canada and leads their advocacy and regulatory efforts in support of a trusted, sustainable, and socially responsible legal cannabis industry. C3's current efforts are focused on the legal industry's ability to create jobs, growth and progress, through the elimination of the excise tax on medical cannabis, reform of the cannabis beverage equivalency formula, and expungement of criminal records for minor cannabis convictions amongst other initiatives.

 

"Valens is an established cannabis industry leader whose commitment to product safety and innovation are making an important contribution to the success of Canada's legal cannabis industry," said George Smitherman, President & CEO of C3. "Their experience, expertise and industry relationships are welcome assets in support of C3's ongoing advocacy and regulatory efforts."

 

For more information on C3 and its advocacy efforts, please visit www.cannabis-council.ca.

 

Investors can trade these stocks and other ideas on our site using our  list of top stock trading apps including Robinhood , Acorn, Stash  and others.

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

 

The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio ,  Google Play Music and most audio platforms available.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news,  third party stock research , guest posts and original  articles and podcasts in leading stock sectors.  Learn about investing in stocks and get  investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast ,  Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and  the AI Eye Podcast.     

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.  Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 


  Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

 

Wednesday 9 June 2021

Enactment of Adult-Use Marijuana Laws Doesn't Encourage Drugged Driving Behavior

Enactment of Adult-Use Marijuana Laws Doesn't Encourage Drugged Driving Behavior

Cannabis Deal Tracker: Investment and M&A Activity in the Cannabis Industry May 31st - June 4th, 2021

Cannabis Deal Tracker: Investment and M&A Activity in the Cannabis Industry May 31st - June 4th, 2021

Cannabis Stock News: Tilray (NASDAQ | TSX: TLRY) Announces Launch of New Medical Cannabis Brand, Symbios

Cannabis Stock News: Tilray (NASDAQ | TSX: TLRY) Announces Launch of New Medical Cannabis Brand, Symbios

Link Reservations Inc/LinkResPet (OTC: $LRSV) @res_pet to Sell #MedicinalMushroom and #Cannabidiol (#CBD) Wellness Products on Amazon US ( $AMZN)

 

Link Reservations Inc/LinkResPet (OTC: $LRSV) @res_pet to Sell #MedicinalMushroom and #Cannabidiol (#CBD) Wellness Products on Amazon US ( $AMZN)

 

London, UK– June 9, 2021 - Breaking CBD stock news from Investorideas.com Newswire- Link Reservations Inc. (OTC: LRSV), a provider of medicinal mushroom and cannabidiol (CBD) wellness products for both humans and pets, announces it intends start selling its LinkResPet and DailyLifeCBD products on Amazon.com. The Company would stock its LinkResPet cat and dog CBD products as well as its DailyLifeCBD mushroom-infused Immune product, on the online platform.

 

Read this news, featuring LRSV in full at https://www.investorideas.com/news/2021/cannabis/06091LRSV-Sell-CBD-Amazon.asp

 

Rene Lauritsen, Link Reservations Inc CEO commented: “This is something we are very excited about as it will open up our retail avenues to include more sources of revenue. Amazon has become ever-present in our society, and a great first point of purchase for anyone looking for CBD, hemp or mushroom products. By selling on Amazon, we would be able to reach a larger audience looking for wellness solutions and so increase our revenue. Our intention is to initially stock our products on Amazon US but we hope to also operate on the UK based platform (amazon.co.uk) at a later date.”

 

LinkResPet’s products consist of CBD tinctures for dogs and cats. While DailyLifeCBD has a functional mushroom and CBD range of products including its DailyLifeCBD Immune tincture, as well as other CBD products in the pipeline. All products are made with the highest quality hemp oil and are lab tested, THC and GMO free. The hemp oil used in LRSV products comes from organically grown certified U.S. and European hemp. The Company ensures that its products undergo a rigorous process of quality control and testing using the latest scientific methods.

 

For more information about LinkResPet or to purchase CBD products for pets, please visit www.linkrespet.com or follow them on Twitter on @res_pet

 

For more information about DailyLifeCBD, the Company’s range of CBD and mushroom product for people, please visit: https://dailylifecbd.com/


About Link Reservations Inc.
Link Reservations Inc is a CBD and wellness product provider dedicated to improving the health and life conditions of both people and pets worldwide. Its trades through its two brands; LinkResPet and DailyLifeCBD. LinkResPet develops and markets hemp-based CBD products for cats, dogs and horses. DailyLifeCBD provides everyday hemp based CBD wellness and mushroom products for people. The Company has operations in both the US and Europe.

Forward-Looking Statements & Disclaimers:
The information in this Press Release includes certain "forward-looking" statements within the meaning of the Safe Harbor provisions of Federal Securities Laws, as that term is defined in section 27a of the United States Securities Act of 1933, as amended, and section 21e of the United States Securities Exchange Act of 1934, as amended. Statements in this document, which are not purely historical, are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Investors are cautioned that such statements are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including the future financial performance of the Company. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date of this release, and the Company undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date of this release except as required by law.

Link Reservations Inc
400 Thames Valley Park Drive
Reading Berkshire RG6 1 PT
United Kingdom
Phone: +44 330 808 0897

 

Paid News -Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure : this news release featuring LRSV is a paid for news release on Investorideas.com  More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

About Investorideas.com https://www.investorideas.com/About/

 

Sign up for free stock news alerts at Investorideas.com

https://www.investorideas.com/Resources/Newsletter.asp

 

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others. 

 

Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories

 

Weeding through the Winners in Cannabis Stocks (TSX: WEED) (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB)

Weeding through the Winners in Cannabis Stocks (TSX: WEED) (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB) : Weeding through the Winners in Canna...